Physician profile
Bruce Fleishman
NPI 1508812769
$1,331.60
in general payments reported to CMS, 2019-2025
18 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $185 · 2021: $84.09 · 2022: $80.21 · 2023: $434 · 2024: $230 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $791.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Circulation INC | $303.82 | 2019-2025 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Novartis Pharmaceuticals Corporation | $253.42 | 2019-2025 | |
| Silk Road Medical, INC. | $100.49 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Novo Nordisk INC | $90.70 | 2023-2025 | Ozempic, Wegovy |
| Boston Scientific Corporation | $87.64 | 2024-2025 | Bodyguardian, Cds - Mct/Cem Monitoring, Cds - Other |
| Pfizer INC. | $78.04 | 2024-2025 | |
| Astrazeneca Pharmaceuticals Lp | $75.04 | 2019-2024 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $59.39 | 2023-2024 | Camzyos |
| Sanofi-Aventis U.S. LLC | $55.40 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.04 | 2023-2024 | Jardiance |
| Regeneron Healthcare Solutions, INC. | $36.96 | 2019 | |
| Abbott Laboratories | $30.98 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $29.25 | 2023 | Verquvo |
| Janssen Pharmaceuticals, INC | $28.59 | 2020-2021 | |
| Amgen INC. | $19.32 | 2024 | Repatha |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardinal Health 200 LLC | $15.27 | 2019 | |
| Chiesi USA, INC. | $13.96 | 2021 | |
| Gilead Sciences, INC. | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Fleishman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.